Takayuki Miki
8PUBLICATIONS
2CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (8)
Sort by Publication Date:
|Aug 05, 2024
Influence of the COVID-19 pandemic on the achievement of guideline targets for HbA1c, blood pressure, and LDL cholesterol in people with diabetes in Japan.Shingo Kuwajima, Takahito Itoh, Tatsuya Sato
|Jun 23, 2021
Characteristics of patients with emergency attendance for severe hypoglycemia and hyperglycemia in a general hospital in Japan.Keisuke Endo, Takahito Itoh, Masaya Tanno
|Nov 19, 2019
Reply to the comment of Hirota et al. on "Accuracy of flash glucose monitoring in insulin-treated patients with type 2 diabetes".Tatsuya Sato, Hiroto Oshima, Kei Nakata
|May 16, 2019
Longitudinal impact of dapagliflozin treatment on ventricular repolarization heterogeneity in patients with type 2 diabetes.Tatsuya Sato, Takayuki Miki, Shinya Furukawa
|Jan 22, 2019
Canagliflozin, a sodium-glucose cotransporter 2 inhibitor, normalizes renal susceptibility to type 1 cardiorenal syndrome through reduction of renal oxidative stress in diabetic rats.Yukishige Kimura, Atsushi Kuno, Masaya Tanno
|Oct 12, 2018
Accuracy of flash glucose monitoring in insulin-treated patients with type 2 diabetes.Tatsuya Sato, Hiroto Oshima, Kei Nakata
Pageof 2
